Satsuma Pharmaceuticals Inc (STSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2007 | 03-2007 | 12-2006 | 09-2006 | 06-2006 | |
| Interest Income | 194,061 | 174,902 | 159,748 | 148,208 | 126,720 |
| Interest Expense | 105,021 | 94,286 | 85,874 | 78,175 | 65,671 |
| Interest Income (Net of Interest Expense) | 89,040 | 80,616 | 73,874 | 70,033 | 61,049 |
| Non-Interest Income | 24,778 | 23,448 | 22,842 | 18,451 | 15,130 |
| Sales | 113,818 | 104,064 | 96,716 | 88,484 | 76,179 |
| Credit Losses Provision | 3,975 | 4,225 | 4,705 | 4,698 | 4,650 |
| Non Interest Expenses | 69,891 | 65,669 | 59,842 | 55,302 | 46,989 |
| Pre-tax Income | 39,952 | 34,170 | 32,169 | 28,484 | 24,540 |
| Income Tax | 12,971 | 11,249 | 9,909 | 9,145 | 7,609 |
| Other Income | 144,973 | 128,456 | 118,043 | 106,659 | 90,211 |
| Net Income | $26,981 | $22,921 | $22,260 | $19,339 | $16,931 |
| EPS Basic Continuous Ops | 34.68 | 33.33 | 38.30 | 34.49 | 31.75 |
| EPS Basic Total Ops | 34.87 | 33.55 | 38.82 | 34.21 | 31.58 |
| EPS Diluted Continuous Ops | 34.33 | 32.90 | 37.68 | 34.13 | 31.46 |
| EPS Diluted Total Ops | 34.21 | 32.89 | 37.50 | 34.21 | 31.58 |
| EBITDA(a) | $N/A | $N/A | $N/A | $N/A | $N/A |